Neumann, Helmut |
| Active, not recruiting | N/A | 600 | Europe | CAD with LCI for colorectal polyp detection | Johannes Gutenberg University Mainz | Focus of the Study is to Evaluate a New Developed Deep-learning Computer-aided Detection System in Combination With LCI for Colorectal Polyp Detection | 08/20 | 09/20 | | |
NCT04457934: Effectiveness of PLENVU in the General Screening Population and Patients With IBD |
|
|
| Recruiting | N/A | 290 | Europe | Plenvu | Johannes Gutenberg University Mainz | IBD, Healthy | 01/21 | 08/21 | | |
| Recruiting | N/A | 404 | Europe | Plenvu | Johannes Gutenberg University Mainz | Quality Standards in Colonoscopy, Patient Education, Acceptance of Bowel-preparation | 01/21 | 06/21 | | |
NCT04734912: Evaluation of Transnasal Endoscopy During COVID-19 Pandemic |
|
|
| Recruiting | N/A | 500 | Europe | gastroscopy in transnasal techique | Johannes Gutenberg University Mainz | Endoscopy | 06/21 | 12/21 | | |
| Completed | N/A | 830 | Europe, US | Computer Aided Detection (CADe) | NEC Corporation, Meditrial Europe Ltd., Meditrial USA Inc. | Colorectal Cancer, Adenoma Colon, Polyp of Colon | 09/24 | 09/24 | | |
Fuji AI, NCT04894708: Study on the Use of Artificial Intelligence (Fujifilm) for Polyp Detection in Colonoscopy |
|
|
| Recruiting | N/A | 1572 | Europe | colonoscopy | Universitätsklinikum Hamburg-Eppendorf, FUJIFILM Deutschland, Branch office of FUJIFILM Europe GmbH | Screening Colonoscopy, Colonoscopic Control After Polypectomy, Suspected Colon Polyps | 05/24 | 09/24 | | |
Hess, Georg |
| Active, not recruiting | 3 | 500 | Europe, Canada, Japan, US, RoW | Pirtobrutinib, LOXO-305, LY3527727, Ibrutinib, Imbruvica, Acalabrutinib, Calquence, Zanubrutinib, Brukinsa | Loxo Oncology, Inc., Eli Lilly and Company | Lymphoma, Mantle-Cell | 12/25 | 07/26 | | |
BRUIN CLL-322, NCT04965493 / 2021-000043-49: A Trial of Pirtobrutinib (LOXO-305) Plus Venetoclax and Rituximab (PVR) Versus Venetoclax and Rituximab (VR) in Previously Treated Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma (CLL/SLL) |
|
|
| Recruiting | 3 | 600 | Europe, Canada, Japan, US, RoW | Pirtobrutinib, LOXO-305, LY3527727, Venetoclax, Venclexta, Venclyxto, Rituximab, Rituxan, MabThera, Truxima, Riabni, Ruxience | Loxo Oncology, Inc., Eli Lilly and Company | Chronic Lymphocytic Leukemia, Small Lymphocytic Lymphoma | 04/26 | 01/27 | | |
SYMPHONY-1, NCT04224493 / 2019-003333-42: A Study to Assess the Efficacy, Safety, Pharmacodynamics, and Pharmacokinetics of Tazemetostat in Combination With Lenalidomide Plus Rituximab Versus Placebo in Combination With Lenalidomide Plus Rituximab in Adult Patients at Least 18 Years of Age With Relapsed/Refractory Follicular Lymphoma. |
|
|
| Recruiting | 3 | 612 | Europe, Canada, US, RoW | Tazemetostat, EPZ-6438, IPN60200, Placebo oral tablet, Lenalidomide, Rituximab | Epizyme, Inc. | Relapsed/Refractory Follicular Lymphoma, Follicular Lymphoma, Refractory Follicular Lymphoma | 03/26 | 03/29 | | |
|
|
|
|
|
|
|
| Recruiting | 2 | 150 | Europe | KTE-X19, Ibrutinib | Christian Schmidt, MD, Johannes Gutenberg University Mainz | Mantle Cell Lymphoma | 06/31 | 12/31 | | |
Treede, Hendrik |
| Completed | N/A | 68 | Europe | BIOVALVE prosthesis | Biotronik AG, Medstar Health Research Institute | Heart Valve Diseases, Aortic Valve Stenosis | 03/18 | 05/23 | | |
NCT02732691: JENAVALVE AS EFS TRIAL: Pericardial TAVR Aortic Stenosis Study |
|
|
| Active, not recruiting | N/A | 68 | Europe, US, RoW | JenaValve Pericardial TAVR System | JenaValve Technology, Inc. | Aortic Valve Stenosis, Heart Valve Diseases, Heart Diseases, Cardiovascular Diseases, Ventricular Outflow Obstruction | 05/19 | 04/24 | | |
TAVIS, NCT05536310: Registry - Trilogy Heart Valve System for Management of Patients With Aortic Valve Disease |
|
|
| Not yet recruiting | N/A | 600 | Europe | Transcatheter Aortic Valve Implantation (TAVI) | JenaValve Technology, Inc. | Aortic Valve Stenosis, Aortic Valve Regurgitation, Aortic Valve Stenosis With Insufficiency, Constriction, Pathologic, Aortic Valve Disease, Heart Valve Diseases, Cardiovascular Diseases in Old Age, Ventricular Outflow Obstruction, Aortic Stenosis, Severe | 10/23 | 10/27 | | |
| Recruiting | N/A | 1247 | Europe, Canada, US | Edwards PASCAL System, Transcatheter Mitral Valve repair (TMVr), Abbott Mitraclip System | Edwards Lifesciences | Degenerative Mitral Valve Disease, Mitral Regurgitation, Mitral Insufficiency, Functional Mitral Regurgitation | 01/25 | 04/30 | | |
| Not yet recruiting | N/A | 1016 | NA | Transcatheter Aortic Valve Replacement (TAVR) using Trilogy THV System, SAVR | JenaValve Technology, Inc. | Aortic Regurgitation, Aortic Valve Insufficiency, Aortic Insufficiency | 02/26 | 02/36 | | |
| Recruiting | N/A | 650 | Europe, Canada, Japan, US, RoW | Medtronic Evolut PRO+ TAVR System, or Evolut FX TAVR System, and guideline-directed management and therapy (GDMT) | Medtronic Cardiovascular | Moderate Aortic Valve Stenosis | 02/26 | 12/34 | | |
| Recruiting | N/A | 500 | Europe, Canada, US | MitraClip™ device implantation, Mitral Valve Repair Surgery | Abbott Medical Devices | Mitral Valve Regurgitation | 04/26 | 04/34 | | |
APOLLO-EU, NCT05496998: Transcatheter Mitral Valve Replacement in Patients With Severe Symptomatic Mitral Regurgitation - Trial |
|
|
| Recruiting | N/A | 400 | Europe | Medtronic Intrepid™ TMVR TF System | Medtronic Cardiovascular | Mitral Regurgitation | 08/29 | 12/38 | | |
Gori, Tommaso |
| Completed | 4 | 200 | Europe | Quantitative flow ratio, Assessment of angiographic severity of the stenosis | Johannes Gutenberg University Mainz | Coronary Artery Disease | 04/23 | 04/24 | | |
| Completed | 4 | 1105 | Europe | Iron, Saline, salin | Universitätsklinikum Hamburg-Eppendorf, Deutsches Zentrum für Herz-Kreislauf-Forschung (DZHK), Charite University, Berlin, Germany | Systolic Heart Failure, Iron Deficiency | 05/24 | 05/24 | | |
EXAMINE-CAD, NCT05294887: Randomized Trial to Examine a Differential Therapeutic Response in Symptomatic Patients With Non-obstructive Coronary Artery Disease |
|
|
| Recruiting | 4 | 132 | Europe | Bisoprolol, beta blocker, Diltiazem, Placebo | Charite University, Berlin, Germany, Deutsches Zentrum für Herz-Kreislauf-Forschung (DZHK) | Coronary Microvascular Dysfunction, Microvascular Angina, Vasospasm, Coronary, Vasospastic Angina, Prinzmetal Angina, Coronary Artery Disease | 06/24 | 06/24 | | |
EPIDAURUS, NCT04981041: Escalated Single Platelet Inhibition for One Month Plus NOAC in Patients With Atrial Fibrillation and ACS Undergoing PCI |
|
|
| Recruiting | 4 | 2334 | Europe | Prasugrel or Ticagrelor, Clopidogrel | Ludwig-Maximilians - University of Munich | Acute Coronary Syndrome, Atrial Fibrillation | 12/24 | 06/25 | | |
| Recruiting | 4 | 100 | Europe | RFR, FFR | Johannes Gutenberg University Mainz | Coronary Artery Disease | 06/25 | 06/25 | | |
| Recruiting | 4 | 2500 | Europe, RoW | Pressure Microcatheter guided strategy - PIOS MC, Pressure Wire guided strategy - PIOS - PW, Pressure Microcatheter guided strategy - Standard of care, Pressure Wire guided strategy - Standard of care | CoreAalst BV, Insight Lifetech Co., Ltd. | Coronary Artery Disease, Acute Coronary Syndrome | 06/26 | 06/30 | | |
| Completed | N/A | 185 | Europe | Comprehensive Cardiovascular magnetic resonance (CMR), Blood sampling, TTE (EchoErgo), Invasive pressure-volume (PV) Loops, Left ventricular (LV) biopsy | Goethe University, Deutsches Zentrum für Herz-Kreislauf-Forschung (DZHK) | Heart Failure With Normal Ejection Fraction | 12/22 | 12/22 | | |
| Completed | N/A | 20 | Europe | Swan-Ganz catheter placed in the coronary sinus - deflated, Swan-Ganz catheter placed in the coronary sinus - inflated | Johannes Gutenberg University Mainz | Microvascular Coronary Artery Disease | 08/23 | 08/23 | | |
MICAT, NCT02180178: Mainz Intracoronary Database. The Coronary Slow-flow and Microvascular Diseases Registry |
|
|
| Recruiting | N/A | 1000 | Europe | observational only- no intervention | Johannes Gutenberg University Mainz | Coronary Artery Disease, Microvascular Dysfunction | 09/28 | 09/28 | | |
TIPTAP-I, NCT03714750: Treatment of Coronary Bifurcation Lesions: Comparing Reverse T and Protrusion Versus Double-kissing and Crush Stenting |
|
|
| Completed | N/A | 50 | Europe | DK crush, Reverse TAP | Tommaso Gori | Coronary Artery Disease | 04/24 | 04/24 | | |
| Recruiting | N/A | 1000 | Europe | Assessment of microvascular function with intracoronary hemodilution | Johannes Gutenberg University Mainz | Microvascular Disease | 10/24 | 10/29 | | |
| Active, not recruiting | N/A | 399 | Europe, US | Shockwave Medical Coronary IVL System | Shockwave Medical, Inc. | Coronary Artery Disease | 12/24 | 04/28 | | |
| Recruiting | N/A | 144 | Europe | Coronary sinus reducer, Optimal medical therapy | Johannes Gutenberg University Mainz, Neovasc Inc. | Coronary Microvascular Disease, Refractory Angina | 10/25 | 10/29 | | |
| Not yet recruiting | N/A | 40 | Europe | microvascular function assessment | Johannes Gutenberg University Mainz | Microvascular Coronary Artery Disease | 07/27 | 08/27 | | |
| Recruiting | N/A | 1000 | Europe | Coronary physiology assessment, Parameters of coronary physiology in response to microvascular vasodilators (adenosine, papaverine) and acetylcholine | Johannes Gutenberg University Mainz | Coronary Microvascular Disease, Coronary Vasospasm | 08/28 | 08/28 | | |
Schuster, Michael |
| Recruiting | 3 | 2470 | Europe | red blood cell transfusion trigger | Johann Wolfgang Goethe University Hospital, Wuerzburg University Hospital | Transfusion-dependent Anemia, Surgery, Anemia | 12/24 | 12/25 | | |
| Completed | 2 | 203 | Europe, US, RoW | Olorofim, F901318 | F2G Biotech GmbH, Iqvia Pty Ltd | Invasive Fungal Infections | 02/23 | 02/23 | | |
| Active, not recruiting | 2 | 196 | US | asciminib, ABL001 | Novartis Pharmaceuticals | Chronic Myelogenous Leukemia - Chronic Phase | 09/25 | 10/27 | | |
| Completed | 1/2 | 15 | Europe, Canada, US, RoW | Modakafusp Alfa, TAK-573, Daratumumab | Takeda, Takeda Development Center Americas, Inc. | Multiple Myeloma | 05/24 | 05/24 | | |
DREAMM 12, NCT04398745: A Study of Belantamab Mafodotin Monotherapy in Multiple Myeloma Participants With Normal and Varying Degree of Impaired Renal Function |
|
|
| Recruiting | 1 | 36 | Europe, US, RoW | Belantamab mafodotin, GSK2857916 | GlaxoSmithKline | Multiple Myeloma | 02/25 | 02/25 | | |
NCT01351545: A Multicenter Access and Distribution Protocol for Unlicensed Cryopreserved Cord Blood Units (CBUs) |
|
|
| Recruiting | N/A | 99999 | US | A multicenter access and distribution protocol for unlicensed cryopreserved cord blood units (CBUs) | Center for International Blood and Marrow Transplant Research, National Marrow Donor Program | Hematologic Malignancies, Inherited Disorders of Metabolism, Inherited Abnormalities of Platelets, Histiocytic Disorders, Acute Myelogenous Leukemia (AML or ANLL), Acute Lymphoblastic Leukemia (ALL), Other Acute Leukemia, Chronic Myelogenous Leukemia (CML), Myelodysplastic (MDS) / Myeloproliferative (MPN) Diseases, Other Leukemia, Hodgkin Lymphoma, Non-hodgkin Lymphoma, Multiple Myeloma/ Plasma Cell Disorder (PCD), Inherited Abnormalities of Erythrocyte Differentiation or Function, Disorders of the Immune System, Autoimmune Diseases, Severe Aplastic Anemia | 10/41 | 10/41 | | |
Bardeleben, Ralph Von |
| Recruiting | N/A | 1247 | Europe, Canada, US | Edwards PASCAL System, Transcatheter Mitral Valve repair (TMVr), Abbott Mitraclip System | Edwards Lifesciences | Degenerative Mitral Valve Disease, Mitral Regurgitation, Mitral Insufficiency, Functional Mitral Regurgitation | 01/25 | 04/30 | | |
Reshape-HF2, NCT02444338: A Clinical Evaluation of the Safety and Effectiveness of the MitraClip System in the Treatment of Clinically Significant Functional Mitral Regurgitation |
|
|
| Completed | N/A | 505 | Europe, RoW | MitraClip, standard of care | University Medical Center Goettingen, University Medical Center Goettingen | Mitral Valve Insufficiency | 04/24 | 04/24 | | |
| Recruiting | N/A | 2650 | Europe, Canada, Japan, US, RoW | Left Atrial Appendage Occlusion (Amplatzer Amulet LAA Occluder), Amplatzer Amulet LAA Occluder, Non-Vitamin K Oral Antagonists, NOAC | Abbott Medical Devices | Atrial Fibrillation, Stroke, Bleeding | 08/27 | 08/30 | | |
| Recruiting | N/A | 800 | Europe, Canada, US, RoW | | Universitätsklinikum Hamburg-Eppendorf, Montreal Heart Institute, University Hospital, Bordeaux | Mitral Regurgitation | 03/25 | 12/30 | | |
| Active, not recruiting | N/A | 200 | Europe, RoW | Tendyne™ Mitral Valve System, Transcatheter Mitral Valve Implantation (TMVI) | Abbott Medical Devices | Mitral Valve Regurgitation | 05/25 | 05/29 | | |
| Recruiting | N/A | 590 | Europe, RoW | Navitor Transcatheter Aortic Valve and FlexNav Delivery System | Abbott Medical Devices | Symptomatic Severe Aortic Stenosis | 06/25 | 02/36 | | |
| Recruiting | N/A | 500 | Europe, Canada, US | MitraClip™ device implantation, Mitral Valve Repair Surgery | Abbott Medical Devices | Mitral Valve Regurgitation | 04/26 | 04/34 | | |
APOLLO-EU, NCT05496998: Transcatheter Mitral Valve Replacement in Patients With Severe Symptomatic Mitral Regurgitation - Trial |
|
|
| Recruiting | N/A | 400 | Europe | Medtronic Intrepid™ TMVR TF System | Medtronic Cardiovascular | Mitral Regurgitation | 08/29 | 12/38 | | |
Schattenberg, Jörn M |
NATiV3, NCT04849728: A Phase 3 Study Evaluating Efficacy and Safety of Lanifibranor Followed by an Active Treatment Extension in Adult Patients With (NASH) and Fibrosis Stages F2 and F3 ( ) |
|
|
| Recruiting | 3 | 1000 | Europe, Canada, US, RoW | IVA337, Lanifibranor, Placebo | Inventiva Pharma | NASH - Nonalcoholic Steatohepatitis | 09/25 | 09/26 | | |
| Recruiting | N/A | 100 | Europe | Intermittent fasting, Time restricted feeding, DGE diet | Johannes Gutenberg University Mainz, University of Turin, Italy | Fatty Liver Disease, Fatty Liver, Fatty Liver, Nonalcoholic | 09/24 | 12/24 | | |
| Recruiting | N/A | 1200 | Europe | UDCA, ursodeoxycholic acid, Ocaliva, obeticholic acid | University of Leipzig, RWTH Aachen University, Zentrum für Klinische Studien Leipzig, Intercept Pharma Europe Limited (IPEL), Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA), University Hospital Erlangen, Medical care center for Gastroenterology, Berlin, Institute for Interdisciplinary Medicine, Hamburg, Leberhilfe Projekt gUG, Cologne, Hannover Medical School | PBC, Primary Biliary Cholangitis | 03/24 | 03/24 | | |
| Recruiting | N/A | 10000 | Europe | | Newcastle University, Newcastle-upon-Tyne Hospitals NHS Trust, Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA), Institute of Cardiometabolism and Nutrition, France, University of Cambridge, Örebro University, Sweden, University of Bern, University of Oxford, University of Turin, Italy, University of Angers, University Hospital, Antwerp, Linkoeping University, University of Helsinki, UMC Utrecht, National and Kapodistrian University of Athens, University of Lisbon, University of Milan, University of Palermo, Catholic University of the Sacred Heart, Wuerzburg University Hospital, RWTH Aachen University, University of Nottingham, Medical University of Vienna, University of Birmingham, University of Florence, Assistance Publique - Hôpitaux de Paris, University Medical Center Mainz | NAFLD, NASH, NASH - Nonalcoholic Steatohepatitis, Fibrosis, Liver, Steatosis of Liver, Hepatocellular Carcinoma, Cardiovascular Diseases, Type 2 Diabetes, Dyslipidaemia, Hypertension, Obesity, Other Associated Comorbidities | 12/30 | 12/30 | | |
Mieghem, Nicolas M Van |
NCT05491200 / 2021-005499-20: Comparison Of Reduced DAPT Followed by P2Y12 Inhibitor Monotherapy With Prasugrel vs stAndard Regimen in STEMI Patients |
|
|
| Recruiting | 4 | 1608 | Europe, RoW | Prasugrel based short DAPT, Prasugrel based standard DAPT, OCT guided revascularization, Angio guided revascularization | Research Maatschap Cardiologen Rotterdam Zuid, Abbott Medical Devices | ST Elevated Myocardial Infarction, Dual Antiplatelet Therapy | 08/26 | 08/28 | | |
REDOX TAVI, NCT04171726: Rotterdam EDOXaban Leaflet Evaluation in Patients After Transcatheter Aortic Valve Implantation |
|
|
| Recruiting | 3 | 100 | Europe | Edoxaban | Erasmus Medical Center, Daiichi Sankyo, Inc. | Aortic Valve Stenosis | 06/23 | 09/23 | | |
SURTAVI, NCT01586910: Safety and Efficacy Study of the Medtronic CoreValve® System in the Treatment of Severe, Symptomatic Aortic Stenosis in Intermediate Risk Subjects Who Need Aortic Valve Replacement (). |
|
|
| Active, not recruiting | N/A | 1746 | Europe, Canada, US | Medtronic CoreValve® System Transcatheter Aortic Valve Implantation (TAVI), Surgical Aortic Valve Replacement (SAVR), Medtronic CoreValve® Evolut R System Transcatheter Aortic Valve Implantation (TAVI) | Medtronic Cardiovascular | Severe Aortic Stenosis | 07/18 | 11/26 | | |
NCT04147884: A Feasibility Study of the Millipede Transcatheter Annuloplasty Ring System in Patients With Functional Mitral Regurgitation |
|
|
| Active, not recruiting | N/A | 4 | US, RoW | Millipede Transcatheter Annuloplasty Ring System (Millipede System) | Boston Scientific Corporation | Mitral Regurgitation Functional, Mitral Valve Disease, Cardiovascular Diseases | 12/21 | 11/26 | | |
| Recruiting | N/A | 250 | Europe | Coronary computed tomography angiography | Erasmus Medical Center | Coronary Artery Disease | 10/22 | 10/23 | | |
NCT03621501: Direct Complete Versus Staged Complete Revascularization in Patients Presenting With Acute Coronary Syndromes and Multivessel Disease |
|
|
| Active, not recruiting | N/A | 1525 | Europe | Percutaneous coronary intervention, PCI | Erasmus Medical Center, Biotronik SE & Co. KG | Acute Coronary Syndrome | 10/22 | 10/26 | | |
PLUTO-II, NCT06204783: Real-time Pressure Volume Loop Monitoring as a Guide for Enhanced Understanding of Changes in Elemental Cardiovascular Physiology During Therapeutic Strategies Aiming for Hemodynamic Optimization. Cohort II: Structural Heart Interventions |
|
|
| Recruiting | N/A | 157 | Europe | Pressure volume (PV) loop measurement | Erasmus Medical Center | Heart Failure, Valvular Heart Disease, Aortic Stenosis, Mitral Insufficiency, Tricuspid Insufficiency | 05/24 | 05/25 | | |
| Active, not recruiting | N/A | 252 | Europe, Canada | Transcatheter Aortic Valve Implantation with ACURATE Neo Aortic Bioprosthesis | Erasmus Medical Center, Boston Scientific Corporation | Aortic Valve Stenosis | 12/22 | 02/24 | | |
| Recruiting | N/A | 150 | Europe | Virtual Reality Immersion | Erasmus Medical Center | Aortic Stenosis, Severe, Anxiety | 12/22 | 05/23 | | |
NCT04799769: Safety and Performance Study of Large Hole Vascular Closure Device - FRONTIER V Study |
|
|
| Recruiting | N/A | 90 | Europe | Percutaneous arterial closure device | Vivasure Medical Limited | Percutaneous Arteriotomy Closure | 01/23 | 03/23 | | |
PRECISE TAVI, NCT04473443: Addition of Computer Simulations to Minimize Adverse Events After Transcatheter Aortic Valve Implantation |
|
|
| Recruiting | N/A | 200 | Europe | FEops HEARTguideTM | Erasmus Medical Center, Feops | Aortic Valve Stenosis, Bicuspid Cardiac Valve | 02/23 | 06/23 | | |
NCT02661451: Transcatheter Aortic Valve Replacement to UNload the Left Ventricle in Patients With ADvanced Heart Failure (TAVR UNLOAD) |
|
|
| Active, not recruiting | N/A | 178 | Europe, Canada, US | SAPIEN 3 THV, Optimal Heart Failure Therapy | Cardiovascular Research Foundation, New York, Cardialysis BV, Avania | Aortic Valve Stenosis | 02/23 | 02/25 | | |
| Recruiting | N/A | 150 | Europe | Coronary Physiology assessment | Erasmus Medical Center | Aortic Valve Stenosis, Mitral Regurgitation, Coronary Artery Disease, Fractional Flow Reserve | 03/23 | 03/23 | | |
PLUTO-I, NCT05909280: Real-time Pressure Volume Loop Monitoring as a Guide for Enhanced Understanding of Changes in Elemental Cardiovascular Physiology During Therapeutic Strategies Aiming for Hemodynamic Optimization. Cohort I: Veno-arterial Extracorporeal Membrane Oxygenation |
|
|
| Recruiting | N/A | 20 | Europe | Pressure-volume loop measurements | Erasmus Medical Center | Extracorporeal Membrane Oxygenation, Cardio/Pulm: Heart Failure | 11/24 | 12/24 | | |
NCT06181240: Modification of Coronary Calcium With Laser Based Intravascular Lithotripsy for Coronary Artery Disease (FRACTURE) |
|
|
| Recruiting | N/A | 400 | Europe | Intravascular lithotripsy | Bolt Medical | Coronary Artery Disease, Coronary Artery Calcification | 04/25 | 03/26 | | |
IABP ON-TIME, NCT06414187: Clinical Effects of Intra-aortic Balloon Support in Early Acute Coronary Syndrome and Non-Acute Coronary Syndrome Related Cardiogenic Shock |
|
|
| Not yet recruiting | N/A | 400 | Europe | Intra-Aortic Balloon Pump | Erasmus Medical Center, Arrow International LCC (Subsidiary of Teleflex Inc.) | Cardiogenic Shock | 06/27 | 06/27 | | |
CorCinch-HF, NCT04331769: Clinical Evaluation of the AccuCinch® Ventricular Restoration System in Patients Who Present with Symptomatic Heart Failure with Reduced Ejection Fraction (HFrEF): the CORCINCH-HF Study |
|
|
| Recruiting | N/A | 400 | Europe, US, RoW | AccuCinch Ventricular Restoration System, Guideline-Directed Medical Therapy | Ancora Heart, Inc. | Heart Failure with Reduced Ejection Fraction (HFrEF), Dilated Cardiomyopathy | 12/26 | 12/30 | | |
DTU-STEMI, NCT03947619: Primary Unloading and Delayed Reperfusion in ST-Elevation Myocardial Infarction: the STEMI-DTU Trial |
|
|
| Active, not recruiting | N/A | 527 | Europe, Canada, US | Impella CP® placement prior to reperfusion with Primary PCI | Abiomed Inc. | ST Elevation (STEMI) Myocardial Infarction of Anterior Wall | 09/24 | 10/30 | | |
PROVE, NCT05539573: ACURATE neo2™ - Post Market Safety and Performance Surveillance in Aortic Stenosis |
|
|
| Active, not recruiting | N/A | 1043 | Europe | Planned TAVI with the ACURATE neo2™ aortic bioprosthesis and ACURATE neo2™ transfemoral delivery system. | University of Leipzig, National University of Ireland, Galway | Aortic Stenosis | 04/25 | 04/25 | | |
| Recruiting | N/A | 590 | Europe, RoW | Navitor Transcatheter Aortic Valve and FlexNav Delivery System | Abbott Medical Devices | Symptomatic Severe Aortic Stenosis | 06/25 | 02/36 | | |
NCT05069558: Comparing PFO Outcomes of the Occlutech Flex II PFO Occluder to Standard of Care PFO Occlusion |
|
|
| Active, not recruiting | N/A | 450 | Europe, Canada, US | Investigational PFO Closure Device, Standard of Care PFO Closure Device | Occlutech International AB | Stroke, Patent Foramen Ovale, PFO | 11/25 | 10/26 | | |
| Recruiting | N/A | 650 | Europe, Canada, Japan, US, RoW | Medtronic Evolut PRO+ TAVR System, or Evolut FX TAVR System, and guideline-directed management and therapy (GDMT) | Medtronic Cardiovascular | Moderate Aortic Valve Stenosis | 02/26 | 12/34 | | |
| Recruiting | N/A | 400 | Europe, Canada, US | Evolut R/PRO bioprosthesis, Edwards Sapien S3/Ultra bioprosthesis | Erasmus Medical Center | Valve Heart Disease | 05/26 | 05/26 | | |
APOLLO-EU, NCT05496998: Transcatheter Mitral Valve Replacement in Patients With Severe Symptomatic Mitral Regurgitation - Trial |
|
|
| Recruiting | N/A | 400 | Europe | Medtronic Intrepid™ TMVR TF System | Medtronic Cardiovascular | Mitral Regurgitation | 08/29 | 12/38 | | |
| Active, not recruiting | N/A | 52 | Europe, US | | Catharina Ziekenhuis Eindhoven | Aortic Valve Stenosis | 10/24 | 10/28 | | |
| Not yet recruiting | N/A | 456 | Europe | Impella 5.5, Inotropes | Amsterdam UMC, location VUmc, Abiomed Inc. | Cardiogenic Shock | 10/27 | 07/28 | | |
TRACE-NL, NCT05628779: Evaluating Edge-to-edge Transcatheter Tricuspid Valve Repair in Patients With Severe Symptomatic Tricuspid Regurgitation |
|
|
| Enrolling by invitation | N/A | 150 | Europe | TriClip TTVr system (Abbott Vascular), PASCAL TTVr system (Edwards Lifesciences) | St. Antonius Hospital, ZonMw: The Netherlands Organisation for Health Research and Development | Tricuspid Valve Regurgitation, Nonrheumatic, Cardiac Catheterization, Heart Failure, Right Sided, Valve Regurgitation, Tricuspid | 11/27 | 11/27 | | |
ATLAS TAVI, NCT04914481: Anatomic Stenosis Severity as a Prognostic Marker in Patients With Low-Flow Low-Gradient Aortic Stenosis Undergoing TAVI |
|
|
| Recruiting | N/A | 1500 | Europe, Canada, RoW | | Universitätsklinikum Hamburg-Eppendorf, Institut universitaire de cardiologie et de pneumologie de Québec | Low-Flow, Low-Gradient Aortic Stenosis | 12/22 | 12/25 | | |
Wittenmeier, Eva |
| Recruiting | 3 | 2470 | Europe | red blood cell transfusion trigger | Johann Wolfgang Goethe University Hospital, Wuerzburg University Hospital | Transfusion-dependent Anemia, Surgery, Anemia | 12/24 | 12/25 | | |
Schmidt, Marcus |
NeoON, NCT05036005: Neoadjuvant Ontruzant (SB3) in Patients With HER2-positive Early Breast Cancer: An Open-Label |
|
|
| Recruiting | 4 | 108 | Europe | Ontruzant, SB3, Chemotherapy, Pertuzumab | Institut fuer Frauengesundheit, Samsung Bioepis Co., Ltd. | Breast Cancer, Breast Neoplasms, Breast Cancer Female, HER2-positive Breast Cancer | 04/23 | 07/23 | | |
CAPTOR-BC, NCT05452213: Comprehensive Analysis of Spatial, Temporal and Molecular Patterns of Ribociclib Efficacy and Resistance in Advanced Breast Cancer Patients |
|
|
| Recruiting | 4 | 1000 | Europe | Ribociclib | Institut fuer Frauengesundheit, AGO Breast Study Group e.V., Novartis Pharmaceuticals | Breast Cancer, Breast Neoplasms, Breast Neoplasm Female, Breast Cancer Female, HER2-negative Breast Cancer, Hormone Receptor-positive Breast Cancer, Advanced Breast Cancer | 10/24 | 10/26 | | |
| Active, not recruiting | 3 | 1332 | Europe | Capecitabine, Xeloda, Carboplatin, Paraplatin, Cisplatin, Platinol, Sacituzumab govitecan, Trodelvy | German Breast Group, Gilead Sciences, Austrian Breast & Colorectal Cancer Study Group, Spanish Breast Cancer Research Group (GEICAM), ETOP IBCSG Partners Foundation, Cancer Trials Ireland, UNICANCER | HER2-negative Breast Cancer, Triple Negative Breast Cancer | 03/27 | 03/29 | | |
Reiser, Iris |
PH002-TP-II, NCT03272477 / 2016-005157-21: Study to Compare Neoadjuvant Combination of Trastuzumab and Pertuzumab With Concurrent Taxane Chemotherapy or Endocrine Therapy and Quality of Life Assessment Under Adjuvant Therapy in Operable HER2+/HR+ Breast Cancer Patients |
|
|
| Completed | 2 | 257 | Europe | Perjeta Injectable Product, Pertuzumab, Herceptin, Trastuzumab, Tamoxifen, Paclitaxel, Epirubicin, Cyclophosphamide, Anastrozole, Letrozole, Exemestane, Leuprorelin acetate, Goserelin, Leuporelin acetate, Biopsy, Surgery | Palleos Healthcare GmbH, Roche Pharma AG, WSG WOMEN´S HEALTHCARE STUDY GROUP, Cankado GmbH | Breast Neoplasms | 07/20 | 03/24 | | |
| Completed | 2 | 416 | Europe | Atezolizumab 840 MG in 14 ML Injection, Tecentriq, Atezolizumab 1200 MG in 20 ML Injection, Carboplatin, Paclitaxel, Epirubicin, Cyclophosphamide, Biopsy Arm A, Biopsy Arm B, Surgery | Palleos Healthcare GmbH, Roche Pharma AG, Phaon Scientific GmbH, University Hospital, Essen, University Hospital Erlangen | Triple-negative Breast Cancer | 07/23 | 10/24 | | |
Verhelst, Xavier |
| Active, not recruiting | 3 | 238 | Europe, Canada, Japan, US, RoW | Linerixibat, Placebo | GlaxoSmithKline | Pruritus | 10/24 | 01/25 | | |
| Recruiting | 3 | 251 | Europe, Canada, Japan, US, RoW | Linerixibat | GlaxoSmithKline, GlaxoSmithKline LLC, GlaxoSmithKline Research & Development Limited | Cholestasis | 02/27 | 02/27 | | |
| Completed | 2 | 62 | Europe, Canada, US, RoW | EP547, Placebo | Escient Pharmaceuticals, Inc, Escient Pharmaceuticals, Inc. | Pruritus | 07/24 | 09/24 | | |
VISTAS, NCT04663308 / 2020-003027-41: A Study to Evaluate Efficacy and Safety of an Investigational Drug Named Volixibat in Patients With Itching Caused by Primary Sclerosing Cholangitis (PSC) |
|
|
| Recruiting | 2 | 200 | Europe, Canada, US, RoW | Volixibat, SHP626, Placebo | Mirum Pharmaceuticals, Inc., Mirum Pharmaceuticals, Inc. | Primary Sclerosing Cholangitis | 09/25 | 12/25 | | |
| Not yet recruiting | N/A | 4500 | Europe | | Assistance Publique - Hôpitaux de Paris, European Society for Organ Transplantation (ESOT)-European Liver and Intestine Transplant Association (ELITA)ELITA, University Luxembourg (UNILU) - ELIXIR, Italian National Transplant Centre (CNT), La Fe University hospital Valencia (HULAFE) | Decompensated Liver Cirrhosis, Primary Biliary Cholangitis, Primary Sclerosing Cholangitis, Hepato-cellular Carcinoma | 12/27 | 11/28 | | |
| Not yet recruiting | N/A | 630 | Europe | Standardized assessments, guided tumor biopsy and biobanking, Standardized assessments and biobanking | Assistance Publique - Hôpitaux de Paris, University Luxembourg (UNILU) - ELIXIR, Hospital Universitario La Fe, ECRIN EUROPEAN CLINICAL RESEARCH INFRASTRUCTURE NETWORK (ECRIN), Ophiomics - Precision Medicine, EF CLIF, INSERM 1149, INSERM U1052 | Decompensated Liver Cirrhosis, Primary Biliary Cholangitis, Primary Sclerosing Cholangitis, Hepato-cellular Carcinoma | 01/27 | 10/27 | | |
| Active, not recruiting | N/A | 156 | Europe | Cessation of ongoing treatment | University Hospital, Antwerp, Universiteit Antwerpen | Chronic Hepatitis B | 12/25 | 12/25 | | |
CHANCE, NCT04613921: Liver Transplantation in Patients With CirrHosis and Severe Acute-on-Chronic Liver Failure: iNdications and outComEs |
|
|
| Recruiting | N/A | 3000 | Europe, Canada, Japan, US, RoW | Observational Protocol | European Foundation for Study of Chronic Liver Failure | Liver Diseases, Liver Cirrhosis, Acute-On-Chronic Liver Failure, Liver Transplant; Complications | 12/25 | 12/26 | | |
| Recruiting | N/A | 600 | Europe | GlycoTransplantTest | University Hospital, Ghent, Fund for Scientific Research, Flanders, Belgium, University Hospital, Antwerp, Universitaire Ziekenhuizen KU Leuven, Cliniques universitaires Saint-Luc- Université Catholique de Louvain | Liver Transplant Failure, Prognostic Biomarkers | 04/26 | 05/27 | | |
GLITCA, NCT05866783: Serum Glycomics as Prognostic and Diagnostic Biomarkers of Disease Recurrence in Liver Transplant Recipients With Hepatocellular Carcinoma |
|
|
| Recruiting | N/A | 500 | Europe | HCCRecurrencePrognosticScore, HCCRecurrenceDiagnosticScore | University Hospital, Ghent, University Hospital, Antwerp, Universitaire Ziekenhuizen KU Leuven, Cliniques universitaires Saint-Luc- Université Catholique de Louvain | Prognostic Biomarker, Liver Transplantation, Diagnostic Biomarker, Hepatocellular Carcinoma | 01/27 | 01/38 | | |
Wörns, Marcus-Alexander |
CaboCHILD, NCT04454762: A Study to Evaluate the Safety, Tolerability and Efficacy of Cabozantinib in Patients With Hepatocellular Carcinoma and Impaired Liver Function |
|
|
| Recruiting | 2 | 20 | Europe | Cabozantinib, Cabometyx | Johannes Gutenberg University Mainz, Interdisciplinary Center Clinical Trials (IZKS), University Medical Center Mainz | Hepatocellular Carcinoma | 08/23 | 02/24 | | |
Emrich, Tilman |
| Recruiting | N/A | 8000 | Europe | | Johann Wolfgang Goethe University Hospital, Kerckhoff Klinik, Johannes Gutenberg University Mainz | Heart Failure, Cardiomyopathies, Inflammatory Disease, Coronary Artery Disease, Chronic Kidney Diseases | 02/30 | 02/30 | | |
EPIPHANY, NCT05877768: Evaluation of PCD-CT Based Image Parameters in the Assessment and Quantification of Coronary Artery Disease |
|
|
| Not yet recruiting | N/A | 3000 | Europe | Photon Counting Detector Coronary Computed Tomography Angiography, Photon-Counting Detector CT (Naeotom Alpha, Siemens Healthineers) | University Medical Center Mainz | Coronary Artery Disease | 06/33 | 06/33 | | |
Bardeleben, Stephan von |
AHEAD, NCT03339115: European Feasibility Study of the Cardiovalve Transfemoral Mitral Valve System |
|
|
| Recruiting | N/A | 30 | Europe | Cardiovalve Transfemoral Mitral Valve | Cardiovalve Ltd., Meditrial Europe Ltd., Meditrial SrL | Mitral Regurgitation, Mitral Valve Disease | 12/24 | 12/29 | | |
| Active, not recruiting | N/A | 1070 | Europe, US | Edwards EVOQUE System, Transcatheter tricuspid valve replacement, Optimal Medical Therapy | Edwards Lifesciences | Tricuspid Valve Regurgitation, Tricuspid Valve Insufficiency, Tricuspid Valve Disease, Heart Valve Diseases, Cardiovascular Diseases, Heart Failure | 06/24 | 12/29 | | |